These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32381178)

  • 1. Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases.
    Dionísio PA; Amaral JD; Rodrigues CMP
    Int Rev Cell Mol Biol; 2020; 353():31-82. PubMed ID: 32381178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necroptosis in neurodegenerative diseases: a potential therapeutic target.
    Zhang S; Tang MB; Luo HY; Shi CH; Xu YM
    Cell Death Dis; 2017 Jun; 8(6):e2905. PubMed ID: 28661482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
    Shrestha A; Mehdizadeh Gohari I; McClane BA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
    [No Abstract]   [Full Text] [Related]  

  • 4. Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases.
    Yuan J; Amin P; Ofengeim D
    Nat Rev Neurosci; 2019 Jan; 20(1):19-33. PubMed ID: 30467385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of Necroptosis in Neurodegenerative Diseases.
    Shao L; Yu S; Ji W; Li H; Gao Y
    Neurochem Res; 2017 Aug; 42(8):2117-2126. PubMed ID: 28382594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necroptosis: a crucial pathogenic mediator of human disease.
    Choi ME; Price DR; Ryter SW; Choi AMK
    JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature.
    Regoni M; Valtorta F; Sassone J
    Eur J Neurosci; 2024 Mar; 59(6):1079-1098. PubMed ID: 37667848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis: A Novel Pathway in Neuroinflammation.
    Yu Z; Jiang N; Su W; Zhuo Y
    Front Pharmacol; 2021; 12():701564. PubMed ID: 34322024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor.
    Wang L; Chang X; Feng J; Yu J; Chen G
    Front Cell Dev Biol; 2019; 7():393. PubMed ID: 32039207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.
    Jacobsen AV; Lowes KN; Tanzer MC; Lucet IS; Hildebrand JM; Petrie EJ; van Delft MF; Liu Z; Conos SA; Zhang JG; Huang DC; Silke J; Lessene G; Murphy JM
    Cell Death Dis; 2016 Jan; 7(1):e2051. PubMed ID: 26775703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.
    Murphy JM; Vince JE
    F1000Res; 2015; 4():. PubMed ID: 27158445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necroptosis: Pathway diversity and characteristics.
    de Almagro MC; Vucic D
    Semin Cell Dev Biol; 2015 Mar; 39():56-62. PubMed ID: 25683283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tale of two domains - a structural perspective of the pseudokinase, MLKL.
    Czabotar PE; Murphy JM
    FEBS J; 2015 Nov; 282(22):4268-78. PubMed ID: 26337687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury.
    Xia K; Zhu F; Yang C; Wu S; Lin Y; Ma H; Yu X; Zhao C; Ji Y; Ge W; Wang J; Du Y; Zhang W; Yang T; Zhang X; He S
    Front Cell Dev Biol; 2020; 8():606119. PubMed ID: 33364238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights into the Mechanism of Necroptosis: The Necrosome As a Potential Therapeutic Target.
    Chen J; Kos R; Garssen J; Redegeld F
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.
    Faergeman SL; Evans H; Attfield KE; Desel C; Kuttikkatte SB; Sommerlund M; Jensen LT; Frokiaer J; Friese MA; Matthews PM; Luchtenborg C; Brügger B; Oturai AB; Dendrou CA; Fugger L
    Cell Death Dis; 2020 May; 11(5):303. PubMed ID: 32358523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.